Top North America Bladder Cancer Therapeutics and Diagnostics Companies, Leaders & Major Players

This list of the top companies of North America Bladder Cancer Therapeutics and Diagnostics is drawn from assessments by Mordor Intelligence analysts and expert advisors via their extensive research to identify the brands, leaders and major players active in North America Bladder Cancer Therapeutics and Diagnostics sector.

Top Bladder Cancer Therapeutics and Diagnostics Companies in North America

  1. Bristol-Myers Squibb Company

  2. AstraZeneca

  3. GlaxoSmithKline

  4. Johnson & Johnson

  5. Roche

*Disclaimer: Top companies sorted in no particular order

North America Bladder Cancer Therapeutics and Diagnostics Market Major Players

North America Bladder Cancer Therapeutics and Diagnostics - Competitive Concentration

North America Bladder Cancer Therapeutics and Diagnostics Market Concentration

List of Bladder Cancer Therapeutics and Diagnostics Companies in North America

  • AstraZeneca PLC

  • Bristol-Myers Squibb Company

  • Eli Lilly and Company

  • F. Hoffmann-La Roche Ltd

  • GlaxoSmithKline PLC

  • Novartis International AG

  • Pfizer Inc.

  • Sanofi SA

  • Johnson & Johnson (Janssen Pharmaceutical)

  • Abbott Laboratories

  • Cepheid

  • Pacific Edge Limited

Get more insights on North America Bladder Cancer Therapeutics and Diagnostics industry from our comprehensive report

Complete your form and get your market insights delivered to your inbox

Takes less than 10 seconds